Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

VTRO - Vitro Biopharma, Inc.


N/A
0   0%

Share volume: 0
Last Updated:

PREVIOUS CLOSE
CHG
CHG%

N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
N/A
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
N/A - N/A
52 WEEK CHANGE
N/A
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
4.461 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Christopher Furman
Region: US
Website: www.vitrobiopharma.com
Employees: 2
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry:
Sector:

We are an innovative biotechnology company targeting autoimmune diseases and inflammatory disorders. Our principal executive offices are located at 3200 Cherry Creek Drive South, Suite 410, Denver, CO.

Recent news